MICHAEL R. DOUGHERTY - 11 Jan 2023 Form 4 Insider Report for IDERA PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Michael R. Dougherty
Issuer symbol
N/A
Transactions as of
11 Jan 2023
Net transactions value
+$14,750
Form type
4
Filing time
12 Jan 2023, 19:00:10 UTC
Previous filing
05 Oct 2022
Next filing
20 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDRA Common Stock Award $14,750 +33,523 +9.8% $0.4400 375,155 11 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock was issued to the reporting person pursuant to his election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees.